webinar register page

Webinar banner
ARC Talks Webinar: Current ATTR landscape: Treatments and Trials
In this ARC TALKS webinar, amyloidosis expert Dr. John L. Berk will present the most current treatment options for ATTR amyloidosis. In addition, Dr. Berk will discuss clinical trials and future research.

Please join us if you would like to learn more about the evolving treatment landscape.

There will be a Q and A session following the presentation.

Dec 9, 2022 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information
ARC TALKS is brought to you by the Amyloidosis Research Consortium. Support for this program is provided by: Alexion/AstraZeneca Rare Diseases, Alnylam Pharmaceuticals, Bridge Bio Pharma, Ionis Pharmaceuticals, Janssen Pharmaceuticals, Pfizer Inc., and Prothena. 


John L. Berk M.D.
Professor of Medicine, Boston University School of Medicine and Assistant Director, Amyloidosis Center @Boston University Medical Center
Known as a leading expert in amyloidosis with a focus on genetic and localized amyloid, John L. Berk, MD, is a Professor of Medicine at the Boston University School of Medicine. Dr. Berk also leads the Pulmonary Consult Service and Medical Intensive Care Units as an Associate Director and is Assistant Director of the Boston University School of Medicine Amyloidosis Center. Dr. Berk is recognized for his contributions in research, previously serving as the Clinical Director of the Amyloid Treatment and Research Program, and has led major initiatives supporting clinical studies and research related to amyloidosis.